| Project/Area Number |
21680032
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (A)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Nerve anatomy/Neuropathology
|
|---|
| Research Institution | National Institute for Longevity Sciences,NCGG |
|---|
Principal Investigator |
TAKEDA Kazuya 独立行政法人国立長寿医療研究センター, 加齢健康脳科学研究部, 流動研究員 (40393160)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥12,350,000 (Direct Cost: ¥9,500,000、Indirect Cost: ¥2,850,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2009: ¥9,880,000 (Direct Cost: ¥7,600,000、Indirect Cost: ¥2,280,000)
|
|---|
| Keywords | 老化性痴呆疾患 / アルツハイマー病 / アミロイド / 痴呆 / 老化 / 脳神経疾患 / 神経科学 / 蛋白質 |
|---|
| Research Abstract |
Deposition of Amyloid beta protein (Aβ) is the hallmark of Alzheimer's disease (AD) brain. Heterogeneity is observed in the N- and C-termini of Aβ species. We have previously reported that N-terminally truncated Aβ, Aβ5-40/42, is deposited in pathological legions of AD brain. To elucidate the mechanisms of generation of and the effect on amyloid formation of Aβ5-40/42, we generated a novel monoclonal antibody specific to C-terminal end of secreted APP (sAPP) and identified a new form of sAPP. In addition, we analyzed biochemical and physical property of mutant Aβ peptides.
|
